Corcept Therapeutics
CORT
#1629
Rank
ยฃ9.91 B
Marketcap
ยฃ91.75
Share price
0.00%
Change (1 day)
71.07%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of June 2026 : ยฃ7.13 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is ยฃ7.13 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ4.53 M-17.95%
2024-12-31ยฃ5.52 M4563.26%
2023-12-31ยฃ0.11 M-87.45%
2022-12-31ยฃ0.94 M142.45%
2021-12-31ยฃ0.38 M-79.18%
2020-12-31ยฃ1.87 M-29.09%
2019-12-31ยฃ2.63 M
2018-12-31N/A
2016-12-31ยฃ11.88 M17.68%
2015-12-31ยฃ10.09 M66.83%
2014-12-31ยฃ6.05 M73.86%
2013-12-31ยฃ3.48 M112.35%
2012-12-31ยฃ1.63 M
2010-12-31N/A-100%
2009-12-31ยฃ0 M-66.04%
2008-12-31ยฃ0.01 M-25.21%
2007-12-31ยฃ0.01 M-31.92%
2006-12-31ยฃ0.02 M-31.53%
2005-12-31ยฃ0.03 M
2003-12-31ยฃ0.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ37.12 B 520,396.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ37.10 B 520,163.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ47.84 B 670,678.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ41.57 B 582,725.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ40.81 B 572,089.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ34.11 B 478,118.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ0.25 B 3,411.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.19 B 2,581.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ3.18 B 44,504.61%๐Ÿ‡บ๐Ÿ‡ธ USA